Related Experiment Video
Updated: Jul 4, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Multi-faceted roles for CXC-chemokines in prostate cancer progression
David J J Waugh1, Catherine Wilson, Angela Seaton
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL. d.waugh@qub.ac.uk
Abstract:
CXC-chemokines play an essential role in co-ordinating the function of the immune system. Increasingly, these small signaling molecules are recognized in facilitating communication between multiple cell types within the tumor microenvironment. This review will summarize the role of two members of this family, CXCL12 (stromal cell derived factor-1) and CXCL8 (interleukin-8) in promoting the disease progression of prostate cancer, the most prevalent non-cutaneous cancer in men in western society and the second leading cause of death from cancer in men. Evidence for a role of these chemokines in underpinning the development and progression of this disease is supported by examination of prostate tissue and serum samples from prostate cancer patients, from biochemical and molecular investigations conducted on representative cell-based models of this disease and from observation of CXC-chemokine promoted growth and systemic dissemination of human prostate tumors in experimental in vivo models. The future potential of employing strategies to attenuate chemokine expression or alternatively to selectively block chemokine receptor signaling to effect greater long-term control or enhanced therapeutic response in this disease is also discussed.
Insights
CXC-chemokines like CXCL12 and CXCL8 promote prostate cancer progression. Targeting these signaling molecules may offer new therapeutic strategies for better disease control.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- CXC-chemokines are crucial for immune system coordination.
- These signaling molecules mediate cell communication within the tumor microenvironment.
- Prostate cancer is a leading cause of cancer death in men.
Purpose of the Study:
- To review the role of CXCL12 and CXCL8 in prostate cancer progression.
- To explore the potential of targeting chemokine pathways for prostate cancer therapy.
Main Methods:
- Analysis of prostate tissue and serum samples from patients.
- Biochemical and molecular investigations using cell-based models.
- In vivo studies of human prostate tumors.
Main Results:
- CXCL12 and CXCL8 are implicated in prostate cancer development and progression.
- Evidence from patient samples, cell models, and in vivo studies supports their role.
- Chemokines promote tumor growth and systemic dissemination.
Conclusions:
- CXCL12 and CXCL8 significantly contribute to prostate cancer progression.
- Strategies to block chemokine signaling may enhance therapeutic responses.
- Targeting chemokines presents a promising avenue for future prostate cancer treatments.
Related Concept Videos
Chemotaxis and Direction of Cell Migration
The Tumor Microenvironment
Cancer Cell Migration through Invadopodia
Mitogens and the Cell Cycle
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Differentiation of Common Myeloid Progenitor Cells

